Variables | Overall | Detect method | Sampling time | |||
RT-PCR | Non-RT-PCR | Pre-treatment | Post-treatment | |||
T stage (T1-2: T3-4) | n | 9 | 4 | 5 | 8 | 1 |
OR | 0.70 | 0.34 | 1.27 | 0.86 | 0.25 | |
95%CI | 0.31 - 1.58 | 0.10 - 1.10 | 0.54 - 3.00 | 0.36 - 2.06 | 0.06 - 1.02 | |
I2 | 35% | 33% | 0% | 30% | / | |
P | 0.39 | 0.07 | 0.58 | 0.73 | 0.05 | |
N stage (N0-1: N2-3) | n | 10 | 4 | 6 | 9 | 1 |
OR | 0.50 | 0.44 | 0.52 | 0.48 | 0.52 | |
95%CI | 0.30 - 0.81 | 0.23 - 0.87 | 0.21 - 1.32 | 0.25 - 0.92 | 0.23 - 1.14 | |
I2 | 0% | 0% | 32% | 4% | / | |
P | 0.005 | 0.02 | 0.17 | 0.03 | 0.10 | |
Clinical stage (I-II: III-IV) | n | 10 | 6 | 4 | 9 | 1 |
OR | 0.68 | 0.69 | 0.76 | 0.73 | 0.55 | |
95%CI | 0.30 - 1.54 | 0.17 - 2.85 | 0.31 - 1.87 | 0.27 - 1.94 | 0.13 - 2.20 | |
I2 | 37% | 57% | 0% | 44% | / | |
P | 0.35 | 0.61 | 0.56 | 0.53 | 0.39 | |
DFS | n | 5 | 3 | 2 | 3 | 2 |
HR | 1.73 | 1.55 | 3.70 | 3.03 | 1.05 | |
95%CI | 1.01 - 2.96 | 0.77 - 3.13 | 0.96 - 14.30 | 1.38 - 6.63 | 0.50 - 2.20 | |
I2 | 0% | 16% | 0% | 0% | 0% | |
P | 0.05 | 0.22 | 0.06 | 0.006 | 0.90 | |
OS | n | 4 | 2 | 2 | 3 | 1 |
HR | 2.53 | 1.58 | 4.02 | 3.19 | 1.36 | |
95%CI | 1.37 - 4.69 | 0.83 - 3.02 | 1.70 - 9.51 | 1.73 - 5.90 | 0.60 - 3.10 | |
I2 | 43% | 0% | 34% | 18% | / | |
P | 0.003 | 0.17 | 0.002 | 0.0002 | 0.46 |